Theodore Alan Huizenga - May 9, 2023 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
SVP, Chief Accounting Officer
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
May 9, 2023
Transactions value $
$63,000
Form type
4
Date filed
5/10/2023, 08:09 PM
Previous filing
Apr 18, 2023
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Options Exercise $63K +3K +10.81% $21.00 30.7K May 9, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RARE Stock Option (Right to Buy) Options Exercise $0 -3K -37.5% $0.00 5K May 9, 2023 Common Stock 3K $21.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 227 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023.
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F3 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter.